Accurate human papillomavirus genotyping by 454 pyrosequencing

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Vaccines for the elderly
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Circumcision and penile human papillomavirus prevalence in human immunodeficiency virus-infected men: heterosexual and men who have sex with men  M.P.
P.-Y. Lévy  Clinical Microbiology and Infection 
B. Schulz, K. Weber, C. Radecke, C. Scheer, M. Ruhnke 
Vaginal self-sampling is an adequate means of screening HR-HPV types in women not participating in regular cervical cancer screening  C. Tamalet, L. Le.
Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia  A. Gradíssimo Oliveira, C. Delgado,
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
A. Bergman, D. Heimer, N. Kondori, H. Enroth 
High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study  H.L. Nielsen, T. Ejlertsen, J. Engberg,
Rapid and sensitive diagnosis of Toxoplasma gondii infections by PCR
Gut bacterial microbiota and obesity
Human papilloma viruses and cancer in the post-vaccine era
Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia  A. Gradíssimo Oliveira, C. Delgado,
Approach to diagnosis of infective endocarditis
Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus  T. Bärnighausen, D.E. Bloom, E.T. Cafiero,
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Clinical significance of signal pattern of high-risk human papillomavirus using a novel fluorescence in situ hybridization assay in cervical cytology 
M. Cogliati, R. D'Amicis, A.M. Tortorano 
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
Migrant health—a cause for concern?
E. Bronska, J. Kalmusova, O. Dzupova, V. Maresova, P. Kriz, J. Benes 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Human papillomavirus (HPV) infection and genotype frequency in the oral mucosa of newborns in Milan, Italy  M. Martinelli, A. Zappa, S. Bianchi, E. Frati,
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Infectious causes of cancer: an evolving educational saga
Virological tools to diagnose and monitor hepatitis C virus infection
B.J. Kocjan, D. Bzhalava, O. Forslund, J. Dillner, M. Poljak 
R. Cantón  Clinical Microbiology and Infection 
A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU  P.G. Higgins, H. Wisplinghoff, O. Krut, H.
B. Edvinsson, M. Lappalainen, B. Evengård 
B.J. Kocjan, D. Bzhalava, O. Forslund, J. Dillner, M. Poljak 
P. Balraj, G. Vestris, D. Raoult, P. Renesto 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR  T. Kallonen, J.
Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China  Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,
Vector control: a cornerstone in the malaria elimination campaign
Training for the infectious diseases speciality in Norway
B. Gordts  Clinical Microbiology and Infection 
A. Pierangeli, F. Cannella, C. Scagnolari, M. Gentile, I. Sciandra, G
S.-M. Sheu, B.-S. Sheu, C.-C. Lu, H.-B. Yang, J.-J. Wu 
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study  H.L. Nielsen, T. Ejlertsen, J. Engberg,
Systematic review of antibiotic consumption in acute care hospitals
Survival of hepatitis A and E viruses in soil samples
Abstracts cont. Clinical Microbiology and Infection
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Vaccines for the elderly
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
Listeriosis: a resurgent foodborne infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Are we losing the fight against malaria one more time?
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Accurate human papillomavirus genotyping by 454 pyrosequencing V. Militello, E. Lavezzo, G. Costanzi, E. Franchin, B. Di Camillo, S. Toppo, G. Palù, L. Barzon  Clinical Microbiology and Infection  Volume 19, Issue 10, Pages E428-E434 (October 2013) DOI: 10.1111/1469-0691.12219 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Results of 454 pyrosequencing analysis of pools of DNA purified from CaSki (HPV16-positive) and HeLa (HPV18-positive) cells. The analysis was performed in duplicate pool samples with PCR primers containing either the multiplex identified MID1 or MID2. Pools contained different proportions of DNA purified from cell lines (and corresponding HPV genome equivalents, GE) ranging from 0.1% (i.e. 1000:1 HPV16 to HPV18) to 80% (i.e. 5:1) HPV16 GE of the total amount of HPV16 and HPV18 GE in samples. Results are represented as absolute number (a) and percentage (b) of reads of HPV18 and HPV16 obtained in samples amplified in duplicate with MID1 and MID2 barcoded primers. Clinical Microbiology and Infection 2013 19, E428-E434DOI: (10.1111/1469-0691.12219) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions